Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Naoko Handa"'
Autor:
Takashi Tanaka, Tomoko Yamashita, Masao Hagihara, Yoshihiro Inamoto, Reiko Ito, Yuji Kikuchi, Takahiro Fukuda, Ichiro Kawashima, Saiko Kurosawa, Akira Ohwada, Sung Won Kim, Kota Yoshifuji, Shigeo Fuji, Yuki Sueki, Naoko Handa, Yasuhiro Matsuura, Takayuki Ozawa
Publikováno v:
ADVANCES IN CELL AND GENE THERAPY. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cc3c64b47e0f398e9d988d164edf81c
https://doi.org/10.1002/acg2.58
https://doi.org/10.1002/acg2.58
Publikováno v:
Open Journal of Blood Diseases. :21-24
Polycythemia vera (PV) is characterized by leukocytosis, thrombocytosis, and low mean capsular volume (MCV). No specific hematological findings are observed in patients with erythrocytosis of other origins. However, recombinant erythropoietin (EPO) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e591454855f6a9cae33f60a9583b14a2
https://doi.org/10.4236/ojbd.2013.31005
https://doi.org/10.4236/ojbd.2013.31005
Publikováno v:
Journal of Clinical and Experimental Hematopathology. 52:85-89
Polycythemia vera (PV) is characterized by low serum total cholesterol despite its association with vascular events such as myocardialand cerebralinfarction. Serum chol esteroll evelhas not been used as a diagnostic criterion for PV since the 2008 re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a33bc56788412960c41fb83a1462f724
https://doi.org/10.3960/jslrt.52.85
https://doi.org/10.3960/jslrt.52.85
Publikováno v:
Oncology Research
A number of large-scale clinical trials have demonstrated that using a combination of oxaliplatin and fluoropyrimidines as an adjuvant chemotherapy for stage II/III colon cancer improved the prognosis. However, there has only been experience in Japan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6548b763a7923d6b51c43203e1e2eb23
https://pubmed.ncbi.nlm.nih.gov/26629945
https://pubmed.ncbi.nlm.nih.gov/26629945
Publikováno v:
Annals of Oncology. 28:ix105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7de8588c56e57dc7423766ed2b9dc551
https://doi.org/10.1093/annonc/mdx621.047
https://doi.org/10.1093/annonc/mdx621.047
Publikováno v:
Annals of Oncology. 26:vii137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e9bf56eabcf1cd3c3e3c31fcc187c10
https://doi.org/10.1093/annonc/mdv472.141
https://doi.org/10.1093/annonc/mdv472.141
Publikováno v:
European Journal of Cancer. 51:S232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef72e536e641ffd8657c98d63b9aa2d5
https://doi.org/10.1016/s0959-8049(16)30673-6
https://doi.org/10.1016/s0959-8049(16)30673-6
Publikováno v:
Annals of Oncology. 25:v100
Objectives: Our department experienced over 100 deaths among only patients with solid cancer every year. Quite a few patients died in hospital under anti-cancer treatment, though some of patients with solid cancer have spent a meaningful time after t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc13f256799baaf20ac856908e46de7f
https://doi.org/10.1093/annonc/mdu436.114
https://doi.org/10.1093/annonc/mdu436.114
Publikováno v:
Annals of Oncology. 24:ix54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f9329358effe29f3dadc2b7143aa4ed
https://doi.org/10.1093/annonc/mdt459.106
https://doi.org/10.1093/annonc/mdt459.106